Literature DB >> 29097367

Sex Chromosome Complement Defines Diffuse Versus Focal Angiotensin II-Induced Aortic Pathology.

Yasir Alsiraj1, Sean E Thatcher1, Eric Blalock1, Bradley Fleenor1, Alan Daugherty1, Lisa A Cassis2.   

Abstract

OBJECTIVE: Aortic pathologies exhibit sexual dimorphism, with aneurysms in both the thoracic and abdominal aorta (ie, abdominal aortic aneurysm [AAA]) exhibiting higher male prevalence. Women have lower prevalence of aneurysms, but when they occur, aneurysms progress rapidly. To define mechanisms for these sex differences, we determined the role of sex chromosome complement and testosterone on the location and progression of angiotensin II (AngII)-induced aortic pathologies. APPROACH AND
RESULTS: We used transgenic male mice expressing Sry (sex-determining region Y) on an autosome to create Ldlr (low-density lipoprotein receptor)-deficient male mice with an XY or XX sex chromosome complement. Transcriptional profiling was performed on abdominal aortas from XY or XX males, demonstrating 1746 genes influenced by sex chromosomes or sex hormones. Males (XY or XX) were either sham-operated or orchiectomized before AngII infusions. Diffuse aortic aneurysm pathology developed in XY AngII-infused males, whereas XX males developed focal AAAs. Castration reduced all AngII-induced aortic pathologies in XY and XX males. Thoracic aortas from AngII-infused XY males exhibited adventitial thickening that was not present in XX males. We infused male XY and XX mice with either saline or AngII and quantified mRNA abundance of key genes in both thoracic and abdominal aortas. Regional differences in mRNA abundance existed before AngII infusions, which were differentially influenced by AngII between genotypes. Prolonged AngII infusions resulted in aortic wall thickening of AAAs from XY males, whereas XX males had dilated focal AAAs.
CONCLUSIONS: An XY sex chromosome complement mediates diffuse aortic pathology, whereas an XX sex chromosome complement contributes to focal AngII-induced AAAs.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  aneurysm; aorta; pathology; sex chromosomes; testosterone

Mesh:

Substances:

Year:  2017        PMID: 29097367      PMCID: PMC5864127          DOI: 10.1161/ATVBAHA.117.310035

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  50 in total

1.  Epidemiology and clinicopathology of aortic dissection.

Authors:  I Mészáros; J Mórocz; J Szlávi; J Schmidt; L Tornóci; L Nagy; L Szép
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

2.  Thoracic aortic aneurysm and dissection: increasing prevalence and improved outcomes reported in a nationwide population-based study of more than 14,000 cases from 1987 to 2002.

Authors:  Christian Olsson; Stefan Thelin; Elisabeth Ståhle; Anders Ekbom; Fredrik Granath
Journal:  Circulation       Date:  2006-12-04       Impact factor: 29.690

Review 3.  Medical management of abdominal aortic aneurysms.

Authors:  Norbert Weiss; Roman N Rodionov; Adrian Mahlmann
Journal:  Vasa       Date:  2014-11       Impact factor: 1.961

4.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

Authors:  A Daugherty; M W Manning; L A Cassis
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

5.  Cine-CMR partial voxel segmentation demonstrates increased aortic stiffness among patients with Marfan syndrome.

Authors:  Parmanand Singh; Zaid Almarzooq; Noel C F Codell; Yi Wang; Mary J Roman; Richard B Devereux; Jonathan W Weinsaft
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

6.  Castration of male mice prevents the progression of established angiotensin II-induced abdominal aortic aneurysms.

Authors:  Xuan Zhang; Sean Thatcher; Congqing Wu; Alan Daugherty; Lisa A Cassis
Journal:  J Vasc Surg       Date:  2014-01-16       Impact factor: 4.268

7.  Androgen increases AT1a receptor expression in abdominal aortas to promote angiotensin II-induced AAAs in apolipoprotein E-deficient mice.

Authors:  Tracy Henriques; Xuan Zhang; Frederique B Yiannikouris; Alan Daugherty; Lisa A Cassis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-01       Impact factor: 8.311

8.  Exogenous 17-β estradiol administration blunts progression of established angiotensin II-induced abdominal aortic aneurysms in female ovariectomized mice.

Authors:  Sean E Thatcher; Xuan Zhang; Shannon Woody; Yu Wang; Yasir Alsiraj; Richard Charnigo; Alan Daugherty; Lisa A Cassis
Journal:  Biol Sex Differ       Date:  2015-06-29       Impact factor: 5.027

9.  Four core genotypes mouse model: localization of the Sry transgene and bioassay for testicular hormone levels.

Authors:  Yuichiro Itoh; Ryan Mackie; Kathy Kampf; Shelly Domadia; Judith D Brown; Rachel O'Neill; Arthur P Arnold
Journal:  BMC Res Notes       Date:  2015-03-07

10.  Sex-Related Differences Between Patients With Symptomatic Acute Aortic Dissection.

Authors:  Buamina Maitusong; Hui-Ping Sun; Dilidaer Xielifu; Maisumu Mahemuti; Xiang Ma; Fen Liu; Xiang Xie; Adila Azhati; Xin-Rong Zhou; Yi-Tong Ma
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

View more
  18 in total

1.  Alan Daugherty: cardiovascular research takes courage to roll with the punches.

Authors:  Brad Li
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

Review 2.  Four Core Genotypes and XY* mouse models: Update on impact on SABV research.

Authors:  Arthur P Arnold
Journal:  Neurosci Biobehav Rev       Date:  2020-09-24       Impact factor: 8.989

Review 3.  Updates of Recent Aortic Aneurysm Research.

Authors:  Frank M Davis; Alan Daugherty; Hong S Lu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-03       Impact factor: 8.311

4.  X Marks the Spot: The Profound Impact of Sex on Aortic Disease.

Authors:  Siddharth K Prakash; Dianna M Milewicz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01       Impact factor: 8.311

5.  Targetable cellular signaling events mediate vascular pathology in vascular Ehlers-Danlos syndrome.

Authors:  Caitlin J Bowen; Juan Francisco Calderón Giadrosic; Zachary Burger; Graham Rykiel; Elaine C Davis; Mark R Helmers; Kelly Benke; Elena Gallo MacFarlane; Harry C Dietz
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

Review 6.  Aortic Aneurysms and Dissections Series: Part II: Dynamic Signaling Responses in Aortic Aneurysms and Dissections.

Authors:  Ying H Shen; Scott A LeMaire; Nancy R Webb; Lisa A Cassis; Alan Daugherty; Hong S Lu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-03-25       Impact factor: 8.311

Review 7.  Annual Report on Sex in Preclinical Studies: Arteriosclerosis, Thrombosis, and Vascular Biology Publications in 2018.

Authors:  Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-12-23       Impact factor: 8.311

8.  Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II-Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertension.

Authors:  Yasir AlSiraj; Sean E Thatcher; Ching Ling Liang; Heba Ali; Mark Ensor; Lisa A Cassis
Journal:  J Pharmacol Exp Ther       Date:  2021-03-11       Impact factor: 4.030

Review 9.  Twenty Years of Studying AngII (Angiotensin II)-Induced Abdominal Aortic Pathologies in Mice: Continuing Questions and Challenges to Provide Insight Into the Human Disease.

Authors:  Hisashi Sawada (澤田悠); Hong S Lu (吕红); Lisa A Cassis; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-01-20       Impact factor: 8.311

10.  Monosomy X in Female Mice Influences the Regional Formation and Augments the Severity of Angiotensin II-Induced Aortopathies.

Authors:  Yasir AlSiraj; Sean E Thatcher; Eric Blalock; Wesley N Saintilnord; Alan Daugherty; Hong S Lu; Wei Luo; Ying H Shen; Scott A LeMaire; Arthur P Arnold; Lisa A Cassis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-15       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.